Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
FSV$139.28-1.92(-1.36%)FirstService Residential selected to manage Ironwood Crossing Homeowners Association in San Tan Valley FirstService Residential, North America's leading property management company, has been selected to provide professional management services to...[11:30:00 AM ET]MELI$1,660.89-19.62(-1.17%)Mercado Libre Sr. Vice President of Advertising Jesus Moreno Sosa Discusses the Future of Advertising[11:05:00 AM ET]PODC$2.16+0.36(+20.01%)PodcastOne (NASDAQ:PODC) Board of Directors Forms Special Committee and Intends to Retain Financial Advisor Following Inbound Strategic Interest[11:00:00 AM ET]III$5.98-0.11(-1.81%)Deloitte is named a Leader in the ISG Provider Lens™: Workday Ecosystem Services 2026 for the fourth time in the US and Europe and the second time in APAC Deloitte has been recognized as a Leader in the ISG Provider Lens™: Workday Ecosystem Services 2026 study across the United States, Europe, and Asia...[11:00:00 AM ET]MWYN$2.63+0.40(+17.96%)Marwynn Holdings Signs Non-Binding MOU with Grenada National Resort to Evaluate Solar-Powered AI Data Center Campus[11:00:00 AM ET]ADSK$241.65-0.45(-0.18%)Autodesk named a Leader in the IDC MarketScape: Worldwide Construction Management Software 2026 Vendor Assessment Autodesk, Inc. (NASDAQ: ADSK) today announced that IDC MarketScape has positioned the company in the Leaders Category of the inaugural IDC...[11:00:00 AM ET]HEINY$43.56+0.77(+1.79%)Europe’s Living Rooms: HEINEKEN and Magnum Photos Release Photoseries Documenting Europe’s Pubs and Bars[10:54:49 AM ET]EQNR$47.94+0.88(+1.87%)Notifiable trading – Equinor ASA[10:34:32 AM ET]NIDB$24.60+0.04(+0.16%)NORTHEAST INDIANA BANCORP, INC. ANNOUNCES THIRD QUARTER 2026 EARNINGS Northeast Indiana Bancorp, Inc., (OTCQB: NIDB), the parent company of First Federal Savings Bank, today announced net income of $1,991,000 ($0.85 per ...[10:34:00 AM ET]FFWC$53.170.00(0.00%)FFW Corporation Announces Earnings for the Quarter Ended September 30, 2026[10:33:15 AM ET]NXST$164.46-1.80(-1.08%)TEGNA Taps Brian Gregory to lead North Carolina Stations WCNC and WFMY[10:30:00 AM ET]GWW$1,342.30-0.42(-0.03%)GRAINGER DECLARES QUARTERLY DIVIDEND W.W. Grainger, Inc. (NYSE: GWW) announced today that its board of directors approved a quarterly cash dividend of $2.49 per share. The dividend is...[10:30:00 AM ET]NTDOY$13.05-0.17(-1.29%)New Indie World Showcase Features Cozy and Chaotic Fun for Nintendo Switch 2 and Nintendo Switch[10:30:00 AM ET]

ABOS · NASDAQ

Acumen Pharmaceuticals, Inc.

$2.38 +0.11 (+4.85%)

Company overview

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate, ACU193, a humanized monoclonal antibody in Phase I clinical-stage targeting soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Market cap
$172M
Employees
61
Headquarters
Newton, VA
Website
acumenpharm.com
CEO
Daniel J. O'Connell
Listed
July 1, 2021
P/E
-1.27
Dividend yield
0.00%

Company financials

Revenue
$0.00
Gross profit
-$46,000
Operating income
-$115M
EBITDA
-$110M
Net income
-$113M
EPS
-$1.87
Total assets
$134M
Total debt
$14.1M
Earnings yield
-78.90%

Price chart

1.552.022.482.943.41
ABOS 1D NASDAQ O2.25H2.37L2.11C2.270.00 (0.00%)Vol454.45K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
ABOSAcumen Pharmaceuticals, Inc. Stock news Acumen Pharmaceuticals: A Speculative Buy Ahead Of November's Alzheimer's Readout Seeking Alpha
ABOSAcumen Pharmaceuticals, Inc. Stock news Acumen Pharmaceuticals, Inc. (ABOS) Q3 2026 Earnings Call Transcript Seeking Alpha
ABOSAcumen Pharmaceuticals, Inc. Stock news Acumen Pharmaceuticals Q3 Earnings Call Highlights MarketBeat
ABOSAcumen Pharmaceuticals, Inc. Press release Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Highlights GlobeNewswire
ABOSAcumen Pharmaceuticals, Inc. Press release Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference GlobeNewswire
ABOSAcumen Pharmaceuticals, Inc. Press release Acumen Pharmaceuticals to Report Third Quarter Financial Results on October 26, 2026 GlobeNewswire
ABOSAcumen Pharmaceuticals, Inc. Stock news 4 Alzheimer's Drug Stocks to Watch on World Alzheimer's Day Zacks Investment Research
ABOSAcumen Pharmaceuticals, Inc. Stock news Acumen Pharmaceuticals, Inc. (ABOS) Analyst/Investor Day Transcript Seeking Alpha
ABOSAcumen Pharmaceuticals, Inc. Press release Acumen Pharmaceuticals to Hold Virtual Investor Day on September 16, 2026 GlobeNewswire
ABOSAcumen Pharmaceuticals, Inc. Stock news Acumen Pharmaceuticals, Inc. (ABOS) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript Seeking Alpha
ABOSAcumen Pharmaceuticals, Inc. Press release Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences GlobeNewswire
ABOSAcumen Pharmaceuticals, Inc. Stock news ADAR1 Capital Management LLC Makes New Investment in Acumen Pharmaceuticals, Inc. $ABOS Defense World
ABOSAcumen Pharmaceuticals, Inc. Stock news Acumen Pharmaceuticals, Inc. (ABOS) Q2 2026 Earnings Call Transcript Seeking Alpha
ABOSAcumen Pharmaceuticals, Inc. Stock news Acumen Pharmaceuticals Q2 Earnings Call Highlights MarketBeat
ABOSAcumen Pharmaceuticals, Inc. Press release Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights GlobeNewsWire
ABOSAcumen Pharmaceuticals, Inc. Press release Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026 GlobeNewsWire
ABOSAcumen Pharmaceuticals, Inc. Stock news All You Need to Know About Acumen Pharmaceuticals (ABOS) Rating Upgrade to Buy Zacks Investment Research
ABOSAcumen Pharmaceuticals, Inc. Stock news Are Medical Stocks Lagging Acumen Pharmaceuticals (ABOS) This Year? Zacks Investment Research
ABOSAcumen Pharmaceuticals, Inc. Press release Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer's Disease Insights at the Alzheimer's Association International Conference (AAIC®) 2026 GlobeNewsWire
ABOSAcumen Pharmaceuticals, Inc. Press release Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer's Disease Insights at the Alzheimer's Association International Conference (AAIC®) 2026 GlobeNewsWire
See more
FAQ

Questions about Acumen Pharmaceuticals, Inc.

What does Acumen Pharmaceuticals, Inc. do?
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate, ACU193, a humanized monoclonal antibody in Phase I clinical-stage targeting soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
What is ABOS's market cap?
Acumen Pharmaceuticals, Inc. (ABOS) is a listed stock with a live quote. The latest market cap on this page is $172M.
Where is Acumen Pharmaceuticals, Inc. headquartered?
Acumen Pharmaceuticals, Inc. is headquartered in Newton, VA.
How do I get ABOS news from the API?
Call GET /v1/news?tickers=ABOS. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does ABOS news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for ABOS, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the ABOS price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs